Try our Advanced Search for more refined results

April 10, 2017

Bristol-Myers Squibb Company, et al v. Zydus Pharmaceuticals (USA) Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 11, 2017

    Bristol-Myers, Pfizer Sue To Halt Generic Blood Thinner

    Bristol-Myers Squibb Co. and Pfizer Inc. hit Zydus Pharmaceuticals Inc. with a patent infringement suit in Delaware federal court Monday, seeking to stop Zydus from receiving U.S. Food and Drug Administration approval for a generic version of their patented blood-thinning drug Eliquis.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login